Antiretroviral Therapy Outcomes in HIV-Infected Children after Adjusting Protease Inhibitor Dosing during Tuberculosis Treatment

BACKGROUND: Modification of ritonavir-boosted lopinavir (LPV/r)-based antiretroviral therapy is required for HIV-infected children co-treated for tuberculosis (TB). We aimed to determine virologic and toxicity outcomes among TB/HIV co-treated children with the following modifications to their antire...

Descripción completa

Detalles Bibliográficos
Autores principales: Frohoff, Cordula, Moodley, Magendhree, Fairlie, Lee, Coovadia, Ashraf, Moultrie, Harry, Kuhn, Louise, Meyers, Tammy
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044164/
https://www.ncbi.nlm.nih.gov/pubmed/21383838
http://dx.doi.org/10.1371/journal.pone.0017273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044164/
https://www.ncbi.nlm.nih.gov/pubmed/21383838
http://dx.doi.org/10.1371/journal.pone.0017273

Ejemplares similares